Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

The Big Winner From the Aurora Cannabis-Organigram Deal: Curaleaf

Organigram is valuing Aurora Cannabis more highly than Curleaf, but that doesn't mean it's the best option for shareholders in the long run.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at fool.com →

More in Finance & Markets

More from Monday 9 November →